The Biomedical Advanced Research and Development Authority (BARDA) has announced an upcoming conference for industry to learn more about U.S. government medical countermeasure requirements, interact with BARDA, and network with other private sector colleagues. The event will take place Oct. 29-31 in Washington, D.C.
BARDA supports the advanced research & development, manufacturing, acquisition, and stockpiling of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) WMD threats, pandemic influenza, and emerging infectious diseases.
BARDA’s work is carried out as part of the Public Health Emergency Medical Countermeasure Enterprise (PHEMCE), a coordinated interagency effort that also includes three primary HHS agencies (NIH, FDA, and CDC), as well as the Departments of Homeland Security, Defense, Veteran’s Affairs, and Agriculture.
Included in the conference agenda is information on the 2012 PHEMCE Strategic Implementation Plan and its goals for medical countermeasure development, manufacturing, approval for use, and deployment; and discussion of new initiatives designed to encourage novel and innovative approaches to the development of countermeasures.
Conference participants may also request one-on-one meetings with BARDA program staff and Office of Acquisitions Management, Contracts and Grants (AMCG) contracting officers. Requests for such meetings should be submitted at the time of registration for the conference.
Conference registration is now available at www.medicalcountermeasures.gov
